194 related articles for article (PubMed ID: 7041242)
1. Effect of Saliment on parotid salivary gland secretion and on xerostomia caused by Sjögren's syndrome.
Donatsky O; Johnsen T; Holmstrup P; Bertram U
Scand J Dent Res; 1982 Apr; 90(2):157-62. PubMed ID: 7041242
[TBL] [Abstract][Full Text] [Related]
2. Effect of Sialor in treatment of xerostomia in Sjögren's syndrome.
Epstein JB; Decoteau WE; Wilkinson A
Oral Surg Oral Med Oral Pathol; 1983 Nov; 56(5):495-9. PubMed ID: 6358997
[TBL] [Abstract][Full Text] [Related]
3. The use of a saliva substitute as treatment for xerostomia in Sjögren's syndrome--a case report.
Weisz AS
Oral Surg Oral Med Oral Pathol; 1981 Oct; 52(4):384-6. PubMed ID: 6946360
[No Abstract] [Full Text] [Related]
4. Clinical evaluation of a commercially available oral moisturizer in relieving signs and symptoms of xerostomia in postirradiation head and neck cancer patients and patients with Sjögren's syndrome.
Rhodus NL; Bereuter J
J Otolaryngol; 2000 Feb; 29(1):28-34. PubMed ID: 10709169
[TBL] [Abstract][Full Text] [Related]
5. A pilot study to test the efficacy of oral administration of interferon-alpha lozenges to patients with Sjögren's syndrome.
Khurshudian AV
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Jan; 95(1):38-44. PubMed ID: 12539025
[TBL] [Abstract][Full Text] [Related]
6. Patient selection criteria for electrostimulation of salivary production in the treatment of xerostomia secondary to Sjogren's syndrome.
Erlichman M
Health Technol Assess Rep; 1990; (8):1-7. PubMed ID: 1369638
[TBL] [Abstract][Full Text] [Related]
7. Progression of salivary gland dysfunction in patients with Sjogren's syndrome.
Pijpe J; Kalk WW; Bootsma H; Spijkervet FK; Kallenberg CG; Vissink A
Ann Rheum Dis; 2007 Jan; 66(1):107-12. PubMed ID: 16728458
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of unstimulated whole saliva flow rate and stimulated parotid flow as confirmatory tests for xerostomia.
Skopouli FN; Siouna-Fatourou HI; Ziciadis C; Moutsopoulos HM
Clin Exp Rheumatol; 1989; 7(2):127-9. PubMed ID: 2736824
[TBL] [Abstract][Full Text] [Related]
9. Salivary lactoferrin in primary Sjögren's syndrome.
Jezequel N; Depasse F; Jouquan J; Lelong A; Roncin S; Pare G; Pennec YL; Youinou P
Clin Exp Rheumatol; 1989; 7(2):123-5. PubMed ID: 2736823
[TBL] [Abstract][Full Text] [Related]
10. Corticosteroid irrigation of parotid gland for treatment of xerostomia in patients with Sjögren's syndrome.
Izumi M; Eguchi K; Nakamura H; Takagi Y; Kawabe Y; Nakamura T
Ann Rheum Dis; 1998 Aug; 57(8):464-9. PubMed ID: 9797551
[TBL] [Abstract][Full Text] [Related]
11. Effect of liposomal local therapy on salivary glands in acoustic radiation force impulse imaging in Sjögren's syndrome.
Hofauer B; Mansour N; Heiser C; Straßen U; Bas M; Knopf A
Clin Rheumatol; 2016 Oct; 35(10):2597-601. PubMed ID: 27572326
[TBL] [Abstract][Full Text] [Related]
12. Effect of xerostomic medications on stimulated salivary flow rate in patients with Sjögren's syndrome.
Simmons DD; Al-Hashimi I; Haghighat N
Quintessence Int; 2000 Mar; 31(3):196-200. PubMed ID: 11203926
[TBL] [Abstract][Full Text] [Related]
13. Treatment of xerostomia: a double-blind trial in 108 patients with Sjögren's syndrome.
Klestov AC; Webb J; Latt D; Schiller G; McNamara K; Young DY; Hobbes J; Fetherston J
Oral Surg Oral Med Oral Pathol; 1981 Jun; 51(6):594-9. PubMed ID: 7019805
[TBL] [Abstract][Full Text] [Related]
14. Xerostomia in Sjögren's syndrome treated with Sali-Synt. A double-blind cross-over trial.
Kaarela K; Mutru O
Scand J Rheumatol; 1982; 11(1):39-40. PubMed ID: 7038859
[TBL] [Abstract][Full Text] [Related]
15. Treatment of oral symptoms in Sjögren's syndrome.
Vissink A; Panders AK; Gravenmade EJ; Vermey A
Scand J Rheumatol Suppl; 1986; 61():270-3. PubMed ID: 3473643
[TBL] [Abstract][Full Text] [Related]
16. Sarcoidosis and Sjögren's syndrome: clinical and salivary evaluation.
Mansour MJ; He C; Al-Farra ST; Khuder SA; Wright JM; Kessler HP; Hinton RJ; Al-Hashimi I
J Oral Pathol Med; 2013 Sep; 42(8):594-9. PubMed ID: 23480241
[TBL] [Abstract][Full Text] [Related]
17. Effects on local blood flux of acupuncture stimulation used to treat xerostomia in patients suffering from Sjögren's syndrome.
Blom M; Lundeberg T; Dawidson I; Angmar-Månsson B
J Oral Rehabil; 1993 Sep; 20(5):541-8. PubMed ID: 10412476
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of rebamipide for the treatment of dry mouth symptoms in patients with Sjögren's syndrome: a double-blind placebo-controlled multicenter trial.
Sugai S; Takahashi H; Ohta S; Nishinarita M; Takei M; Sawada S; Yamaji K; Oka H; Umehara H; Koni I; Sugiyama E; Nishiyama S; Kawakami A
Mod Rheumatol; 2009; 19(2):114-24. PubMed ID: 19089532
[TBL] [Abstract][Full Text] [Related]
19. A randomized controlled trial to verify the irrigation of salivary glands in relieving xerostomia in patients with Sjögren's syndrome.
Du H; Fu Z; Zhong Y; Yuan Y; Zhao J; Ding X; Li S; Gao S; Zhu Y; Song H; Wu H
Front Immunol; 2022; 13():1039599. PubMed ID: 36439107
[TBL] [Abstract][Full Text] [Related]
20. A double-blind crossover trial of CMC- and mucin-containing saliva substitutes.
Visch LL; Gravenmade EJ; Schaub RM; Van Putten WL; Vissink A
Int J Oral Maxillofac Surg; 1986 Aug; 15(4):395-400. PubMed ID: 3091718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
